July’s BJUI – About the Cover
The Article of the Month in July's issue used cancer registries from across France. The corresponding author is based in Strasbourg so this issue’s cover shows The Palais Rohan seen from Strasbourg Cathedral.
©istock.com/railelectropower
Click here for this issue’s Table of Contents
BJUI’s Impact Factor rises to 4.387
3 Comments
/
BJUI's Impact Factor has once again increased, with a steep rise this year to 4.387! The journal has also climbed in to the top 10 for Nephrology and Urology journals.
Editor-in-Chief Prokar Dasgupta and the BJUI Editorial Team would like to thank our readers, authors and reviewers for their dedication and hard work in helping to make this happen.
Congratulations to all those involved.
Consensus guidelines for reporting prostate cancer Gleason Grade
The International Society of Urologic Pathology (ISUP) has endorsed modifications to the Gleason grading system for prostate cancer [1]. Five Grade Groups have been defined with tumors of Grade Group 1 being the least aggressive and having the lowest likelihood of progression, whereas those of Grade Group 5 have the highest likelihood of early systemic spread. This new system provides clearer guidance for pathologists to classify cancers on the basis of gland morphology, and it aligns better…
June’s BJUI – About the Cover
The Article of the Month this issue comes from Copenhagen; the cover image shows the waterfront at Nyhavn, lined by brightly coloured 17th and early 18th century townhouses.
Image ©istock.com/scanrail
Click here for this issue’s Table of Contents
West Coast Urology: Highlights from the AUA 2016 in San Diego… Part 2
By Ben Challacombe (@benchallacombe) and Jonathan Makanjuola (@jonmakurology)
The AUA meeting was starting to hot up with the anticipation of the Crossfire sessions, PSA screening and the MET debate that appeared to rumble on. We attended the MUSIC (Michigan Urological Surgery Improvement Collaborative) session. It is a fantastic physician led program including >200 urologists, which aims to improve the quality of care for men with urological diseases. It is a forum for urologists…
West Coast Urology : Highlights from the AUA 2016 in San Diego… Part 1
By Ben Challacombe (@benchallacombe) and Jonathan Makanjuola (@jonmakurology)
The 2016 AUA returned to the beautiful city of San Diego set on the shores of the Pacific in an excellent conference centre located in the centre of the town adjacent to the Gaslamp district. For a change the wifi was excellent and allowed enhanced levels of social media interaction and urological discussion. Opening these interactions were 2 key sessions which provoked much debate. Firstly the announcement…
May’s BJUI – About the Cover
The Article of the Month for May 2016 is from Tehran, Iran. The cover shows the Azadi Tower, which marks the western entrance to Tehran City.
© istock.com/knet2d
Click here for this issue’s Table of Contents
Bringing Out the Best: 69th USANZ ASM Highlights
The 69th Annual Scientific Meeting (ASM) of the Urological Society of Australia and New Zealand (USANZ) took place at a venue, well-known for its sun and surf – Gold Coast, Queensland. With some of Australia’s best beaches and coast line, the theme of the meeting was fitting: “Bringing out the Best”. Prem Rashid (@premrashid) and Peter Chin (@docpete888) convened a meeting boasting an impressive international and local faculty. Attendees were provided with a healthy balance of scientific…
AUA 2016
[divider scroll]
2.00 pm - 2.05 pm
Welcome Remarks
2.05 pm - 2.25 pm
Freddie C. Hamdy, MD
Treatment Effectiveness in Prostate Cancer -Early Thoughts from the Protect Study
2.25 pm - 2.45 pm
Mark Emberton, MD
What We Know and What We Don’t Know About the Role of MRI in the Prostate Cancer Diagnostic Pathway
2.45 pm - 3.05 pm
Hashim U. Ahmed, MD
Focal Therapy – Ready for Prime Time?
3.05 pm - 3.20 pm
Geoff Coughlin, MD
A Randomised Controlled…
May Editorial: The Current Hot Topics in Functional Urology
For some time, the challenge represented by managing the overactive bladder (OAB) has been dominant in functional urology research. The introduction of new therapies has galvanised the area, with mirabegron showing strong promise for many patients as a monotherapy. In addition, the potential for combined therapy using mirabegron with established antimuscarinics has recently been reported for urgency urinary incontinence [1]. Now that the place of onabotulinum-A injections in refractory cases…